Inhibition of Human MDR1 and BCRP Transporter ATPase Activity by Organochlorine and Pyrethroid Insecticides

Overview

Journal J Biochem Mol Toxicol

Publisher Wiley

Specialties Biochemistry
Molecular Biology
Toxicology

Date 2012 Nov 22

PMID 23169446

Citations 11

Authors

Kristin M Bircsak

Jason R Richardson

Lauren M Aleksunes

Affiliations

Soon will be listed here.

Abstract

Despite the growing evidence suggesting that pesticides contribute to chronic diseases, there is a limited understanding of how these chemicals are removed from cells and whether pesticides can alter the disposition of drugs. The present study examined the effects of two classes of insecticides (organochlorine and pyrethroid) on the ATPase activity of the human multidrug resistance protein 1 (MDR1) and breast cancer resistance protein (BCRP) efflux transporters. Using plasma membranes from cells overexpressing MDR1 and BCRP, it was demonstrated that the organochlorine pesticide dichlorodiphenyltrichloroethane (DDT) (o,p'-DDT and p,p'-DDT isomers) as well as its metabolite (p,p'-dichlorodiphenyldichloroethane), inhibit both MDR1 and BCRP ATPase activity. In addition, p,p'-dichlorodiphenyldichloroethylene, and two pyrethroid pesticides inhibited BCRP ATPase activity between 4 and 7 μM. Additional research is necessary to further characterize the functional inhibition of MDR1 and BCRP activity and determine whether pesticides alter the transporter-mediated disposition of other chemicals.

Citing Articles

Considering developmental neurotoxicity in vitro data for human health risk assessment using physiologically-based kinetic modeling: deltamethrin case study.

Maass C, Schaller S, Dallmann A, Bothe K, Muller D Toxicol Sci. 2023; 192(1):59-70.

PMID: 36637193 PMC: 10025876. DOI: 10.1093/toxsci/kfad007.

ATP-binding cassette (ABC) drug transporters in the developing blood-brain barrier: role in fetal brain protection.

Eng M, Imperio G, Bloise E, Matthews S Cell Mol Life Sci. 2022; 79(8):415.

PMID: 35821142 PMC: 11071850. DOI: 10.1007/s00018-022-04432-w.

Disruption of small molecule transporter systems by Transporter-Interfering Chemicals (TICs).

Nicklisch S, Hamdoun A FEBS Lett. 2020; 594(23):4158-4185.

PMID: 33222203 PMC: 8112642. DOI: 10.1002/1873-3468.14005.

In vitro P-glycoprotein activity does not completely explain in vivo efficacy of novel centrally effective oxime acetylcholinesterase reactivators.

Dail M, Meek E, Chambers H, Chambers J Drug Chem Toxicol. 2018; 42(4):403-408.

PMID: 29722548 PMC: 6215530. DOI: 10.1080/01480545.2018.1461902.

Geographic Differences in Persistent Organic Pollutant Levels of Yellowfin Tuna.

Nicklisch S, Bonito L, Sandin S, Hamdoun A Environ Health Perspect. 2017; 125(6):067014.

PMID: 28686554 PMC: 5714290. DOI: 10.1289/EHP518.

References

Shabbir A, Distasio S, Zhao J, Cardozo C, Wolff M, Caplan A . Differential effects of the organochlorine pesticide DDT and its metabolite p,p'-DDE on p-glycoprotein activity and expression. Toxicol Appl Pharmacol. 2005; 203(2):91-8. DOI: 10.1016/j.taap.2004.07.011. View

Barrera B, Otero J, Egido E, Prieto J, Seelig A, Alvarez A . The anthelmintic triclabendazole and its metabolites inhibit the membrane transporter ABCG2/BCRP. Antimicrob Agents Chemother. 2012; 56(7):3535-43. PMC: 3393426. DOI: 10.1128/AAC.06345-11. View

Airaksinen R, Rantakokko P, Eriksson J, Blomstedt P, Kajantie E, Kiviranta H . Association between type 2 diabetes and exposure to persistent organic pollutants. Diabetes Care. 2011; 34(9):1972-9. PMC: 3161294. DOI: 10.2337/dc10-2303. View

Shapiro A, Fox K, Lam P, Ling V . Stimulation of P-glycoprotein-mediated drug transport by prazosin and progesterone. Evidence for a third drug-binding site. Eur J Biochem. 1999; 259(3):841-50. DOI: 10.1046/j.1432-1327.1999.00098.x. View

Burger H, van Tol H, Boersma A, Brok M, Wiemer E, Stoter G . Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pump. Blood. 2004; 104(9):2940-2. DOI: 10.1182/blood-2004-04-1398. View

Richardson J, Shalat S, Buckley B, Winnik B, OSuilleabhain P, Diaz-Arrastia R . Elevated serum pesticide levels and risk of Parkinson disease. Arch Neurol. 2009; 66(7):870-5. PMC: 3383784. DOI: 10.1001/archneurol.2009.89. View

van der Heijden J, de Jong M, Dijkmans B, Lems W, Oerlemans R, Kathmann I . Development of sulfasalazine resistance in human T cells induces expression of the multidrug resistance transporter ABCG2 (BCRP) and augmented production of TNFalpha. Ann Rheum Dis. 2004; 63(2):138-43. PMC: 1754889. DOI: 10.1136/ard.2002.005249. View

Doyle L, Yang W, Abruzzo L, Krogmann T, Gao Y, Rishi A . A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci U S A. 1998; 95(26):15665-70. PMC: 28101. DOI: 10.1073/pnas.95.26.15665. View

Dunn S, Hedges L, Sampson K, Lai Y, Mahabir S, Balogh L . Pharmacokinetic interaction of the antiparasitic agents ivermectin and spinosad in dogs. Drug Metab Dispos. 2011; 39(5):789-95. DOI: 10.1124/dmd.110.034827. View

10.

Enokizono J, Kusuhara H, Ose A, Schinkel A, Sugiyama Y . Quantitative investigation of the role of breast cancer resistance protein (Bcrp/Abcg2) in limiting brain and testis penetration of xenobiotic compounds. Drug Metab Dispos. 2008; 36(6):995-1002. DOI: 10.1124/dmd.107.019257. View

11.

Sreeramulu K, Liu R, Sharom F . Interaction of insecticides with mammalian P-glycoprotein and their effect on its transport function. Biochim Biophys Acta. 2007; 1768(7):1750-7. DOI: 10.1016/j.bbamem.2007.04.001. View

12.

Le Grand R, Dulaurent S, Gaulier J, Saint-Marcoux F, Moesch C, Lachatre G . Simultaneous determination of five synthetic pyrethroid metabolites in urine by liquid chromatography-tandem mass spectrometry: application to 39 persons without known exposure to pyrethroids. Toxicol Lett. 2011; 210(2):248-53. DOI: 10.1016/j.toxlet.2011.08.016. View

13.

Ueda K, Cardarelli C, Gottesman M, Pastan I . Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine. Proc Natl Acad Sci U S A. 1987; 84(9):3004-8. PMC: 304789. DOI: 10.1073/pnas.84.9.3004. View

14.

Pavek P, Merino G, Wagenaar E, Bolscher E, Novotna M, Jonker J . Human breast cancer resistance protein: interactions with steroid drugs, hormones, the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine, and transport of cimetidine. J Pharmacol Exp Ther. 2004; 312(1):144-52. DOI: 10.1124/jpet.104.073916. View

15.

Pivcevic B, Zaja R . Pesticides and their binary combinations as P-glycoprotein inhibitors in NIH 3T3/MDR1 cells. Environ Toxicol Pharmacol. 2011; 22(3):268-76. DOI: 10.1016/j.etap.2006.04.002. View

16.

Thiebaut F, Tsuruo T, Hamada H, Gottesman M, Pastan I, Willingham M . Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci U S A. 1987; 84(21):7735-8. PMC: 299375. DOI: 10.1073/pnas.84.21.7735. View

17.

Klaassen C, Aleksunes L . Xenobiotic, bile acid, and cholesterol transporters: function and regulation. Pharmacol Rev. 2010; 62(1):1-96. PMC: 2835398. DOI: 10.1124/pr.109.002014. View

18.

Mahon F, Belloc F, Lagarde V, Chollet C, Moreau-Gaudry F, Reiffers J . MDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line models. Blood. 2003; 101(6):2368-73. DOI: 10.1182/blood.V101.6.2368. View

19.

Wang J, Ruan Y, Taylor R, Donovan J, Markowitz J, Devane C . The brain entry of risperidone and 9-hydroxyrisperidone is greatly limited by P-glycoprotein. Int J Neuropsychopharmacol. 2005; 7(4):415-9. DOI: 10.1017/S1461145704004390. View

20.

Gedeon C, Behravan J, Koren G, Piquette-Miller M . Transport of glyburide by placental ABC transporters: implications in fetal drug exposure. Placenta. 2006; 27(11-12):1096-102. DOI: 10.1016/j.placenta.2005.11.012. View